Albert David
Albert David Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Albert David
Start SIPAlbert David Investment Rating
-
Master Rating:
-
Albert David has an operating revenue of Rs. 334.52 Cr. on a trailing 12-month basis. An annual revenue growth of 24% is outstanding, Pre-tax margin of 15% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 29% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 91 which is a GREAT score indicating consistency in earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 75 | 92 | 93 | 74 |
| Operating Expenses Qtr Cr | 66 | 78 | 81 | 64 |
| Operating Profit Qtr Cr | 8 | 14 | 12 | 10 |
| Depreciation Qtr Cr | 2 | 2 | 2 | 2 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 3 | 5 | 3 | 3 |
| Net Profit Qtr Cr | 11 | 20 | 2 | 4 |
Albert David Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 536.31
- 50 Day
- 548.05
- 100 Day
- 557.21
- 200 Day
- 561.94
- 20 Day
- 536.82
- 50 Day
- 549.1
- 100 Day
- 568.36
- 200 Day
- 562.62
Albert David Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 531.82 |
| Second Resistance | 546.24 |
| Third Resistance | 556.02 |
| RSI | 34.5 |
| MFI | 57.19 |
| MACD Single Line | -6.77 |
| MACD | -7.47 |
| Support | |
|---|---|
| First Resistance | 507.62 |
| Second Resistance | 497.84 |
| Third Resistance | 483.42 |
Albert David Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 4,101 | 311,594 | 75.98 |
| Week | 4,237 | 329,835 | 77.85 |
| 1 Month | 3,582 | 253,804 | 70.86 |
| 6 Month | 4,490 | 290,253 | 64.65 |
Albert David Result Highlights
Albert David Synopsis
NSE-Medical-Generic Drugs
Albert David Ltd is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 313.51 Cr. and Equity Capital is Rs. 5.71 Cr. for the Year ended 31/03/2022. Albert David Ltd. is a Public Limited Listed company incorporated on 16/11/1938 and has its registered office in the State of West Bengal, India. Company’s Corporate Identification Number(CIN) is L51109WB1938PLC009490 and registration number is 009490.| Market Cap | 297 |
| Sales | 335 |
| Shares in Float | 0.22 |
| No of funds | 7 |
| Yield | 1.73 |
| Book Value | 1.06 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | |
| Alpha | 0.01 |
| Beta | 0.76 |
Albert David
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 61.99% | 61.99% | 61.99% | |
| Mutual Funds | 0.01% | 0.01% | 0.01% | |
| Insurance Companies | 2.82% | 2.95% | 3.15% | |
| Foreign Portfolio Investors | 0.57% | 0.61% | 0.64% | |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | |
| Individual Investors | 27.61% | 27.69% | 27.49% | |
| Others | 6.99% | 6.74% | 6.71% |
Albert David Management
| Name | Designation |
|---|---|
| Mr. A K Kothari | Executive Chairman |
| Dr. T S Parmar | Managing Director & CEO |
| Mrs. Prabhawati Devi Kothari | Director |
| Mr. Hemal Kampani | Director |
| Mr. Rajiv Singhi | Director |
| Mr. Arindam Sarkar | Director |
| Mr. Shirish G Belapure | Director |
| Dr. Monjori Mitra | Director |
| Mr. A V Kothari | Director |
Albert David Forecast
Price Estimates
Albert David FAQs
What is Share Price of Albert David ?
Albert David share price is ₹519 As on 30 March, 2023 | 16:59
What is the Market Cap of Albert David ?
The Market Cap of Albert David is ₹296.7 Cr As on 30 March, 2023 | 16:59
What is the P/E ratio of Albert David ?
The P/E ratio of Albert David is 8.1 As on 30 March, 2023 | 16:59
What is the PB ratio of Albert David ?
The PB ratio of Albert David is 1.1 As on 30 March, 2023 | 16:59